Multimedia Release 22-Aug-2019

Approved Drug Clears Out Toxic Proteins in a Common Hemoglobin Disorder (2 of 3)

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

Approved Drug Clears Out Toxic Proteins in a Common Hemoglobin Disorder (2 of 3) — image: Mitchell Weiss, MD, PhD, St. Jude Children's Research Hospital Arthur Nienhuis Endowed Chair in Hematology. This material relates to a paper that appeared in the Aug. 21, 2019, issue of *Science Translational Medicine*, published by AAAS. The paper, by C. Lechauve at St. Jude Children's Research Hospital in Memphis, TN; and colleagues was titled, "The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia." view more

Credit: St. Jude Children's Research Hospital

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.